Evaluating the efficacy of harmol in treating herpes simplex virus-induced keratitis

FHS
May 29, 2024
10:06 am

The antiviral efficacy and therapeutic potential of harmol in treating herpes simplex virus type 1 (HSV-1) induced keratitis

Pharmalittle: Three big drugmakers spent less on lobbying after leaving PhRMA; EMA reviews CRO over data concerns

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so familiar routine of online

July 24, 2023

Surge in malaria cases linked to aircraft-transported mosquitoes

Malaria cases resulting from bites of mosquitoes transported by aircraft from areas where is common have increased, according to both a retrospective analysis in France

October 11, 2024

Bristol Myers gets regulatory clearance to close Mirati deal as FTC increases pressure on pharma M&A

Bristol Myers Squibb has the go-ahead from antitrust regulators to complete its $4.8 billion takeover of Mirati. Increased FTC scrutiny has put large pharma mergers

December 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.